LoginRegister
    Merck KEYTRUDA gets Japanese nod for head, neck cancerMerck KEYTRUDA gets Japanese nod for head, neck cancer
    Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons diseaseSunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons...
    Sick, loss-making Hindustan Antibiotics up for sale: MinisterSick, loss-making Hindustan Antibiotics up for sale: Minister
    Glenmark, Mankind Pharma ink licensing pact to co-market diabetes drug RemogliflozinGlenmark, Mankind Pharma ink licensing pact to co-market diabetes drug Remogliflozin
    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner EliquisFIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis
    Trivitron Healthcare gets Ravish Mittal as new Group CFOTrivitron Healthcare gets Ravish Mittal as new Group CFO
    Allergan acute migraine drug Ubrelvy wins USFDA approvalAllergan acute migraine drug Ubrelvy wins USFDA approval
    Merck Ebola vaccine Ervebo to be available at lowest access price for poor nationsMerck Ebola vaccine Ervebo to be available at lowest access price for poor nations
    After Cipla, Glenmark Digihaler secures NPPA nod for separate price; DetailsAfter Cipla, Glenmark Digihaler secures NPPA nod for separate price; Details
    Johnson and Johnson wins baby powder-cancer litigation case in USJohnson and Johnson wins baby powder-cancer litigation case in US
    Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMAGlenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA
    Lupin to provide access to latest developments in field of gastroenterology in IndiaLupin to provide access to latest developments in field of gastroenterology in India
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X